Latest revenue
$0
as of 2025-09-30
Latest net income
$-1.2M
as of 2025-09-30
Net margin
—
as of 2025-09-30
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $31.1M
- Enterprise value
- $31.1M
- P/E (trailing)
- —
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $1.50
- 52-wk low
- $0.75
- Beta
- —
- Shares out
- 28.5M
5-year trend
What this company does
Item 1. Business. Elite Health Systems Inc (the “Company”) is developing Medicare Advantage plans and offering other healthcare related services with a focus on improving and providing access to healthcare, primarily to senior and special needs groups in selected locations. The Company operates through its wholly owned subsidiaries, Elite Health Plan, Inc. (“Elite Health”) and Physician Support Systems Inc. (“PSS”). Elite Health designs, markets, and manages a Medicare Advantage plan or Medicare Part C — a government-approved health plan that delivers Medicare benefits through a managed care or coordinated care model. Since January 2026, Elite Health has operated a Medicare Advantage plan…
AI summary unavailable — showing raw filing excerpt
Generated from EHSI's filing dated 2026-04-15
Key risks
Item 1. Business. Elite Health Systems Inc (the “Company”) is developing Medicare Advantage plans and offering other healthcare related services with a focus on improving and providing access to healthcare, primarily to senior and special needs groups in selected locations. The Company operates through its wholly owned subsidiaries, Elite Health Plan, Inc. (“Elite Health”) and Physician Support Systems Inc. (“PSS”). Elite Health designs, markets, and manages a Medicare Advantage plan or Medicare Part C — a government-approved health plan that delivers Medicare benefits through a managed care or coordinated care model. Since January 2026, Elite Health has operated a Medicare Advantage plan…
AI summary unavailable — showing raw filing excerpt
Generated from EHSI's filing dated 2026-04-15
Profitability
Gross margin
11.5%
Operating margin
-374.9%
4369.3%Net margin
-762.1%
817.8%Return on equity
-146.9%
198.6%Return on assets
-117.1%
146.2%Leverage
Debt / equity
0.25×
642.9%Debt / assets
20.3%
512.6%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q4 2025 2025-12-31 | $1.0M | — | $-5.8M | -467.6% | -564.3% |
Q3 2025 2025-09-30 | $0 | — | $-1.2M | -300.3% | — |
Q2 2025 2025-06-30 | $0 | — | $-441.0K | -1.4% | — |
Q1 2025 2025-03-31 | $0 | — | $-424.0K | -35.9% | — |
Q4 2024 2024-12-31 | $0 | — | $-1.0M | — | — |
Q3 2024 2024-09-30 | $0 | — | $-290.0K | -128.3% | — |
Q2 2024 2024-06-30 | $0 | — | $-435.0K | -0.2% | — |
Q1 2024 2024-03-31 | $0 | — | $-312.0K | — | — |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Services-Specialty Outpatient Facilities, NEC · SIC 8093
Your notes
Keep private notes on EHSI — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$1.4M
Insider selling
$0
Net activity
+$1.4M
Distinct insiders
1
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns EHSI
No institutional holdings on file for EHSI yet.
Source: SEC Form 13F-HR. Updated quarterly (45-day filing lag).
Top questions investors are asking
Coming once EHSI's latest filing finishes processing.